Detalhe da pesquisa
1.
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist.
Bioorg Med Chem Lett
; 21(15): 4622-8, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21700453
2.
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
Bioorg Med Chem Lett
; 21(1): 497-501, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21075628
3.
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists.
Bioorg Med Chem Lett
; 21(10): 3163-7, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21458261
4.
Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.
Bioorg Med Chem Lett
; 15(3): 589-93, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15664818